Analyst Kevin Liu noted that CTG's lower stock price (which had fallen 37% by yesterday's close from highs notched in July) reflects the difficulties the company faces in its solutions and staffing businesses, but that investors are overlooking the opportunities of its medical fraud, waste, and abuse offerings.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs